This review describes the development of monoclonal antibodies and the inception of their use in cancer therapy, their impact on defining cancer biomarkers, and their structural utility in new cancer vaccine development.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490205 | PMC |
http://dx.doi.org/10.1093/infdis/jiu638 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!